pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
LILLY · news · pharmadog
← back to LILLY
News mentioning LILLY
790
stories
24d
Opinion: Why the FDA should not approve an ineffective multicancer screening test
stat
24d
Forbion’s ‘landmark’ €2.3B fundraise to benefit 30 ‘high potential’ biotechs
fiercebiotech
24d
TRex Bio stomps toward $111M IPO, as Retension and Lycia also gear up to go public
fiercebiotech
24d
STAT+: Judges skewer HHS arguments in hearing over Medicare Advantage audits lawsuit
stat
24d
STAT+: Nobel-winning optogenetics research has led to experimental treatments for blindness and Alzheimer’s
stat
24d
STAT+: New Trump regulations would clean up health care pricing disclosures
stat
24d
STAT+: Prices, prices, prices
stat
24d
STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health
stat
24d
Genmab details ovarian cancer data; Lilly's Jaypirca gets a label expansion
endpoints
24d
Lilly doubles down on Gate alliance to unlock new drug class with another $870M+ in biobucks
biospace
25d
Optogenetics researchers win a Nobel Prize; Roche bets on Alector brain drug
biopharma dive
25d
STAT+: Lilly’s Jaypirca approved as first-line CLL therapy
stat
25d
STAT+: Pharmalittle: We’re reading about a Vaxcyte pneumococcal shot, increasing pharma M&A, and more
stat
25d
STAT+: Vaxcyte claims success in bid to beat Pfizer and Merck in lucrative vaccine market
stat
25d
How AI is transforming biopharma manufacturing facilities of the future
biopharma dive
25d
Hospital and pharmaceutical prices are smothering America’s businesses
stat
25d
STAT+: Divergent trial results on cancer vaccines have the field grappling with hard questions
stat
27d
Eli Lilly’s best-ever weight loss data; Sanofi, Regeneron re-up for $1B upfront; and more
endpoints
27d
Gate CEO sees expanded $870M pact with Lilly as ‘vote of confidence’ in biotech’s platform
fiercebiotech
27d
What it’s like to wait for the call from the Nobel Prize committee
stat
27d
Lilly signals move into aesthetics, looking to add products for body, skin and hair
endpoints
27d
This week in charts: Kodiak’s big comeback and Hengrui’s dealmaking
biopharma dive
27d
Access to addiction meds for young people has improved — but retention hasn’t
stat
28d
An Ebola treatment center was burned down as the death toll in Congo passes 4,000
stat
28d
STAT+: Lilly bypasses Australian pharmacies with DTC model
stat
28d
STAT+: Up and down the ladder: The latest comings and goings
stat
28d
STAT+: Pharmalittle: We’re reading about the 340B drug pilot program, an obesity drug disappointment, and more
stat
28d
Kailera, Hengrui’s GLP-1/GIP candidate delivers weight, menstrual benefits to women with PMOS
biospace
28d
Mistrust in science and a juicy gene-editing lawsuit
stat
28d
3 takeaways from a European obesity scientific meeting
biopharma dive
← prev
page 5 of 27
next →
